F144-0202 Screening compound: 2-[4-(1-{[(3-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

F144-0202 Screening compound: 2-[4-(1-{[(3-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide
F144-0202 Screening compound: 2-[4-(1-{[(3-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F144-0202
2-[4-(1-{[(3-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F144-0202

Molecular Formula

C28H28N4O5 (C28 H28 N4 O5)

Compound Name

2-[4-(1-{[(3-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

IUPAC name

2-[4-(1-{[(3-methoxyphenyl)carbamoyl]methyl}-24-dioxo-1234-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

SMILES

CCCNC(Cc(cc1)ccc1N(C(c(cccc1)c1N1CC(Nc2cc(OC)ccc2)=O)=O)C1=O)=O

InChI

InChI=1S/C28H28N4O5/c1-3-15-29-25(33)16-19-11-13-21(14-12-19)32-27(35)23-9-4-5-10-24(23)31(28(32)36)18-26(34)30-20-7-6-8-22(17-20)37-2/h4-14,17H,3,15-16,18H2,1-2H3,(H,29,33)(H,30,34)

InChI Key

DRKQWMVQLVOSOK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27104380

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

500.55

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.418

Distribution Coefficient, logD

2.418

Water Solubility, LogSw

-3.14

Polar Surface Area

85.661

Acid Dissociation Constant (pKa)

11.96

Base Dissociation Constant (pKb)

1.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

F144-0202 in Drug Discovery

Included in Screening Libraries

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Peptidomimetic Library (37031 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F144-0202 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F144-0202?
Check Price and Availability of F144-0202, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F144-0202 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F144-0202
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F144-0202
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F144-0202 available by request